Announced Wed, 2 Sept, 2026 · 18:56 IST

Managing Director resigns, stays on Board as Non-Executive Director

Ceo ResignedKmp ResignedManagement Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+13.1%Reaction day
₹24.10
prior close
₹24.10
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.6%+12.5% vs market
Other Financial Services peers, median of 85sector+0.2%+12.9% vs sector

On the reaction day the stock moved 12.5 pts more than Nifty Microcap 250 and 12.9 pts more than its Other Financial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+13.7
10m
+13.7
15m
+12.0
30m
+18.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+13.1+0.6+12.5+0.2+12.9
Next day
+5.4+1.3+4.1+0.1+5.3
2d
+12.9+1.7+11.2+0.3+12.6
3d
+40.0+2.2+37.8-0.2+40.2
4d
+32.8+2.1+30.7-0.3+33.1
5d
+46.1+1.9+44.3-0.8+47.0
1w
+41.5-1.3+42.8-2.7+44.2
15d
+26.6+1.3+25.2-2.1+28.6
1m
+34.6-0.8+35.5-4.9+39.6
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Other Financial Services peers, median of 85Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Ram Swaroop Joshi has resigned as Managing Director of Nexus Surgical and Medicare Ltd effective September 2, 2026, citing personal reasons. He will continue on the Board as Promoter Non-Executive Director with nil remuneration. He served as MD since 2022 and has over 30 years of experience in production and marketing. The company confirmed no disagreement on operations or financial matters, and he holds no other listed entity directorships.

Likely market impact

Leadership continuity preserved as the outgoing MD stays on the Board. Low impact, no governance red flags raised.